Scott Biller, Chief Scientific Officer at AGIOS PHARMACEUTICALS INC (AGIO), sold 4,300 shares at $73.90 ($322K) on 2018-04-05, disclosed to the SEC on 2018-04-09.
Open-market sale of $322k AGIO by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $73.90 | 1,300 | $96K | 29.9% |
| 2 | $73.90 | 1,300 | $96K | 29.9% |
| 3 | $75.04 | 400 | $30K | 9.3% |
| 4 | $76.17 | 800 | $61K | 18.9% |
| 5 | $77.17 | 500 | $39K | 12.0% |
| Total | $74.81 avg | 4,300 |
| $322K |
| 100% |
| Filing → |
| AGIO | SELL | 2019-03-01 | $585K | — | Filing → |
| AGIO | SELL | 2018-11-07 | $209K | — | Filing → |
| AGIO | SELL | 2018-10-09 | $277K | — | Filing → |